Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review

被引:10
作者
Laport, Ginna G. [1 ]
机构
[1] Stanford Univ, Med Ctr, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA
关键词
Allogeneic transplantation; Hodgkin lymphoma;
D O I
10.1080/10428190802304974
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Autologous hematopoietic cell transplantation (HCT) remains the standard of care for most patients with refractory or relapsed Hodgkin lymphoma (HL). However, the role of allogeneic HCT for this patient population is less defined. In retrospective analyses, allogeneic HCT with myeloablative conditioning confers lower relapse rates compared to autologous HCT but the higher nonrelapse mortality (NRM) offsets any survival benefit. This observed prohibitive NRM has thus fueled the increasing use of allogeneic HCT with reduced intensity conditioning (RIC) especially for patients who have failed a prior autologous HCT. Results with RIC allogeneic HCT appear promising with chemosensitive patients faring the best. Donor leukocyte infusions has been reported to induce durable remissions in relapsed HL patients even in patients who did not receive prior cytoreductive therapy which thus lends support to a graft versus HL effect.
引用
收藏
页码:1854 / 1859
页数:6
相关论文
共 20 条
[1]   Long-term results of blood and marrow transplantation for Hodgkin's lymphoma [J].
Akpek, G ;
Ambinder, RF ;
Piantadosi, S ;
Abrams, RA ;
Brodsky, RA ;
Vogelsang, GB ;
Zahurak, ML ;
Fuller, D ;
Miller, CB ;
Noga, SJ ;
Fuchs, E ;
Flinn, IW ;
O'Donnell, P ;
Seifter, EJ ;
Mann, RB ;
Jones, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (23) :4314-4321
[2]   Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma:: Results of a Spanish prospective cooperative protocol [J].
Alvarez, I ;
Sureda, A ;
Caballero, MD ;
Urbano-Ispizzua, A ;
Ribera, JM ;
Canales, M ;
García-Conde, J ;
Sanz, G ;
Arranz, R ;
Bernal, MT ;
de la Serna, J ;
Díez, JL ;
Moraleda, JM ;
Rubió-Félix, D ;
Xicoy, B ;
Martínez, C ;
Mateos, MV ;
Sierra, J .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) :172-183
[3]   Evidence of a graft-versus-hodgkin lymphoma effect in the setting of extensive bone marrow involvement [J].
Anderlini, Paolo ;
Swanston, Nancy ;
Rashid, Ashif ;
Bueso-Ramos, Carlos ;
Macapinlac, Homer A. ;
Champlin, Richard E. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (04) :478-480
[4]   Fludarabine-meiphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated MD Anderson Cancer Center experience [J].
Anderlini, Paolo ;
Saliba, Rima ;
Acholonu, Sandra ;
Giralt, Sergio A. ;
Andersson, Borje ;
Ueno, Naoto T. ;
Hosing, Chitra ;
Khouri, Issa F. ;
Couriel, Daniel ;
de Lima, Marcos ;
Qazilbash, Muzaffar H. ;
Pro, Barbara ;
Romaguera, Jorge ;
Fayad, Luis ;
Hagemeister, Frederick ;
Younes, Anas ;
Munsell, Mark F. ;
Champlin, Richard E. .
HAEMATOLOGICA, 2008, 93 (02) :257-264
[5]   ALLOGENEIC, SYNGENEIC, AND AUTOLOGOUS MARROW TRANSPLANTATION FOR HODGKINS-DISEASE - THE 21-YEAR SEATTLE EXPERIENCE [J].
ANDERSON, JE ;
LITZOW, MR ;
APPELBAUM, FR ;
SCHOCH, G ;
FISHER, LD ;
BUCKNER, CD ;
PETERSEN, FB ;
CRAWFORD, SW ;
PRESS, OW ;
SANDERS, JE ;
BENSINGER, WI ;
MARTIN, PJ ;
STORB, R ;
SULLIVAN, KM ;
HANSEN, JA ;
THOMAS, ED .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) :2342-2350
[6]   Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: Importance of histology for outcome [J].
Armand, Philippe ;
Kim, Haesook T. ;
Ho, Vincent T. ;
Cutler, Corey S. ;
Koreth, John ;
Antin, Joseph H. ;
LaCasce, Ann S. ;
Jacobsen, Eric D. ;
Fisher, David C. ;
Brown, Jennifer R. ;
Canellos, George P. ;
Freedman, Arnold S. ;
Soiffer, Rohert J. ;
Alyea, Edwin P. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (04) :418-425
[7]  
Armitage JO, 1999, HODGKIN'S DISEASE, P521
[8]  
Burroughs L, 2007, BLOOD, V110, p58A
[9]   Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma [J].
Carella, AM ;
Cavaliere, M ;
Lerma, E ;
Ferrara, R ;
Tedeschi, L ;
Romanelli, A ;
Vinci, M ;
Pinotti, G ;
Lambelet, P ;
Loni, C ;
Verdiani, S ;
De Stefano, F ;
Valbonesi, M ;
Corsetti, MT .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) :3918-3924
[10]   Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease [J].
Gajewski, JL ;
Phillips, GL ;
Sobocinski, KA ;
Armitage, JO ;
Gale, RP ;
Champlin, RE ;
Herzig, RH ;
Hurd, DD ;
Jagannath, S ;
Klein, JP ;
Lazarus, HM ;
McCarthy, PL ;
Pavlovsky, S ;
Petersen, FB ;
Rowlings, PA ;
Russell, JA ;
Silver, SM ;
Vose, JM ;
Wiernik, PH ;
Bortin, MM ;
Horowitz, MM .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :572-578